REFINE-1, a Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial With ATX-101, an Injectable Drug for Submental Fat Reduction

ATX-101 is a safe and efficacious, first-in-class, injectable drug for SMF reduction.